Skip to main content
Fig. 5 | Cancer Imaging

Fig. 5

From: The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

Fig. 5

Detection of an additional, 18F-DOPA-PET/CT-occult metastasis on gadoxetic acid-enhanced MRI. a Contrast-enhanced CT. b 18F-DOPA-PET/CT (fusion image). c T1 GRE fs, arterial phase. d T1 GRE fs, hepatobiliary phase. Hypodense lesion on contrast-enhanced CT with significant 18F-DOPA uptake (a-b, arrowhead). MRI reveals an additional hypervascular, 18F-DOPA-PET/CT-occult metastasis in close proximity (c-d, arrow)

Back to article page